CRE™ RX M00558890Recalls & reported problems
Boston Scientific Corporation · Biliary Balloon Dilatation Catheter · Class 2
All models of CRE RX (9)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 6
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 08714729965442), received between Jan 22, 2019 and Aug 12, 2026 — classified as 1 injury, 5 malfunctions.
The most frequently reported specific device problem is “Detachment of Device or Device Component” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Detachment of Device or Device Component3
- Entrapment of Device2
- Tear, Rip or Hole in Device Packaging2
- Adverse Event Without Identified Device or Use Problem1
- Difficult to Advance1
- Problem with Sterilization1
Patient problems
- No Clinical Signs, Symptoms or Conditions5
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.
MalfunctionAug 12, 2026Detachment of Device or Device Component; Difficult to Advance
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50217663 ↗MalfunctionJul 16, 2026Tear, Rip or Hole in Device Packaging
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25850511 ↗MalfunctionJul 16, 2026Tear, Rip or Hole in Device Packaging
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25850272 ↗InjuryApr 28, 2026Entrapment of Device; Problem with Sterilization; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A CRE RX DILATATION BALLOON WAS USED IN THE ESOPHAGUS, STOMACH AND DUODENUM DURING AN ESOPHAGOGASTRODUODENOSCOPY (EGD) PROCEDURE FOR DIAGNOSTICS PERFORMED ON (B)(6) 2026 DURING A PREVIOUS PROCEDURE PERFORMED ON AN UNKNOWN DATE, WHEN A CRE RX DILATATION BALLOON WAS INSERTED INTO THE WORKING CHANNEL OF THE SCOPE, THE BALLOON GOT STUCK HALFWAY. THE BALLOON WAS REMOVED. IT WAS REPORTED THAT RX TUNNEL BECAME LOOSE FROM THE PURPLE SHAFT AND WAS DETACHED AND LEFT INSIDE THE SCOPE UNNOTICED. DURING ANOTHER PROCEDURE ON (B)(6) 2026, WHILE USING A BIOPSY FORCEPS, IT WAS REPORTED THAT THE DETACHED RX TUNNEL WAS PUSHED OUT FROM THE WORKING CHANNEL OF THE SCOPE AND INTO THE PATIENT. UPON CHECKING, IT WAS POSITIVELY IDENTIFIED TO HAVE COME FROM THE CRE RX BALLOON FROM THE PREVIOUS PROCEDURE. THE DETACHED PART WAS SUCCESSFULLY RETRIEVED WITH A GRASPER. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT AND THE PATIENT'S CONDITION AT THE CONCLUSION OF THE PROCEDURE WAS REPORTED TO BE STABLE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25023650 ↗MalfunctionApr 28, 2026Entrapment of Device; Detachment of Device or Device Component
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A CRE RX DILATATION BALLOON WAS USED DURING A PROCEDURE PERFORMED ON AN UNKNOWN DATE. DURING THE PROCEDURE, WHEN A CRE RX DILATATION BALLOON WAS INSERTED INTO THE WORKING CHANNEL OF THE SCOPE, THE BALLOON GOT STUCK HALFWAY. THE BALLOON WAS REMOVED. IT WAS REPORTED THAT RX TUNNEL BECAME LOOSE FROM THE PURPLE SHAFT AND WAS DETACHED AND LEFT INSIDE THE SCOPE UNNOTICED. DURING A SEPARATE PROCEDURE ON MARCH 27, 2026, THE BIOPSY FORCEPS PUSHED OUT A FOREIGN MATERIAL FROM THE WORKING CHANNEL OF THE SCOPE AND INTO THE PATIENT. UPON CHECKING, IT WAS POSITIVELY IDENTIFIED TO HAVE COME FROM THE CRE RX BALLOON FROM THE PREVIOUS PROCEDURE. THE DETACHED PART WAS SUCCESSFULLY RETRIEVED WITH A GRASPER. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT AND THE PATIENT'S CONDITION AT THE CONCLUSION OF THE PROCEDURE WAS REPORTED TO BE STABLE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25023038 ↗MalfunctionJan 22, 2019Detachment of Device or Device Component; Detachment of Device or Device Component
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A CRE RX BILIARY DILATATION BALLOON WAS USED DURING A DILATION OF THE PAPIL OF VATER PROCEDURE PERFORMED ON (B)(6) 2018. ACCORDING TO THE COMPLAINANT, WHEN THE PACKAGE WAS OPENED, IT WAS NOTED THAT THE BLACK RX TUNNEL OF THE DEVICE WAS DETACHED FROM THE CATHETER. THE PROCEDURE WAS COMPLETED WITH ANOTHER CRE RX BILIARY DILATATION BALLOON. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8267918 ↗
Other CATHETER, BILIARY, DIAGNOSTIC devices
- Hurricane™ RX M00545900Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC2 recalls1 death705 reports
- MUSTANG™ H74939171060470Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC384 reports
- CRE™ PRO M00558710Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC1 recall284 reports
- Hurricane™ RX M00545920Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC2 recalls211 reports
- MUSTANG™ H74939171070470Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC265 reports
- MUSTANG™ H74939171050470Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC212 reports
- Hurricane™ RX M00545940Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC2 recalls109 reports
- MUSTANG™ H74939171100470Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC203 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page